Aggregated
No track record data- Bullish
- 6
- Hold
- 1
- Bearish
- 0
LifeSci Capital
A LifeSci Capital analyst with 6 tracked ratings across 4 distinct tickers has a perfect 5.0 out of 5 stars track record and a 100% success rate on the captured sample.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| AVBP | 2026-05-16 | buy | $42.00 | Aggregated |
| CGON | 2026-05-16 | buy | $108.00 | Aggregated |
| OLMA | 2026-05-16 | buy | $29.00 | Aggregated |
| PVLA | 2026-05-09 | buy | $225.00 | Aggregated |
| IFRX | 2026-04-29 | hold | - | Aggregated |
| DBVT | 2026-04-20 | buy | $46.00 | Aggregated |
| PVLAPALVELLA THERAPEUTICS, INC. COMMON STOCK | 2025-08-04 | unknown | $90.00 | Aggregated |
| ABVX | 2025-07-23 | buy | $101.00 | Aggregated |
| ABVXABIVAX - ADR | 2025-07-23 | unknown | $101.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| AVBP | 1 | 2026-05-16 | Aggregated |
| CGON | 1 | 2026-05-16 | Aggregated |
| OLMA | 1 | 2026-05-16 | Aggregated |
| PVLA | 1 | 2026-05-09 | Aggregated |
| IFRX | 1 | 2026-04-29 | Aggregated |
| DBVT | 2 | 2026-04-20 | Aggregated |
| PVLAPALVELLA THERAPEUTICS, INC. COMMON STOCK | 2 | 2025-08-04 | Aggregated |
| ABVX | 1 | 2025-07-23 | Aggregated |
| ABVXABIVAX - ADR | 2 | 2025-07-23 | Aggregated |